Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hcw Biologics Inc
(NQ:
HCWB
)
0.4700
+0.0490 (+11.64%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hcw Biologics Inc
< Previous
1
2
3
Next >
HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024
August 14, 2024
HCW Biologics just reported results for the second quarter of 2024.
Via
InvestorPlace
HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024
May 15, 2024
HCW Biologics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 12, 2024
Via
Benzinga
HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023
April 01, 2024
HCWB stock results show that HCW Biologics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 27, 2023
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
Via
Benzinga
Looking Into HCW Biologics's Return On Capital Employed
March 29, 2023
Via
Benzinga
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
November 08, 2023
From
HCW Biologics, Inc
Via
GlobeNewswire
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
November 01, 2023
HCW9218 is the lead product candidate of HCW Biologics Inc.
From
HCW Biologics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
September 14, 2023
Via
Benzinga
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
September 06, 2023
Company will provide an update for clinical development and intellectual property programs, Including recent achievements and expected milestones in the next 12 months
From
HCW Biologics, Inc
Via
GlobeNewswire
Nerdy And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
June 08, 2023
The Dow Jones closed higher by around 90 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
$3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
June 01, 2023
The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
May 25, 2023
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Recap: HCW Biologics Q1 Earnings
May 09, 2023
HCW Biologics (NASDAQ:HCWB) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:15 AM. Here's what investors need to know about the announcement. Earnings HCW Biologics reported in-line EPS...
Via
Benzinga
HCW Biologics: Q1 Earnings Insights
May 09, 2023
HCW Biologics (NASDAQ:HCWB) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:15 AM. Here's what investors need to know about the announcement. Earnings HCW Biologics reported in-line EPS...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 27, 2023
Via
Benzinga
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
April 27, 2023
From
HCW Biologics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 06, 2023
Via
Benzinga
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
April 06, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 15, 2023
Via
Benzinga
HCW Biologics Enters CRADA with National Cancer Institute
December 08, 2022
NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer
From
HCW Biologics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 01, 2022
Via
Benzinga
Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
August 31, 2022
US crude oil futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Upgrades
Via
Benzinga
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
August 29, 2022
The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 04, 2022
On Thursday, 49 companies reached new 52-week lows.
Via
Benzinga
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
August 25, 2022
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.
Via
Benzinga
Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session
August 24, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit.
Via
Benzinga
3 Stocks Under $3 Insiders Are Aggressively Buying
June 16, 2022
The Federal Open Market Committee opted to raise fed funds rates by 0.75% on Wednesday to a new target range of between 1.5% and 1.75%. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.